Ketamine For Suicidal Ideation

Summary

Ketamine For Suicidal Ideation is a clinical trial^[1].

Key Facts

• Ketamine For Suicidal Ideation is in the country of United States^[2].
• Ketamine For Suicidal Ideation's instance of is recorded as clinical trial^[3].
• Ketamine For Suicidal Ideation's start time is recorded as +2012-01-31T00:00:00Z^[4].
• Ketamine For Suicidal Ideation's end time is recorded as +2014-09-30T00:00:00Z^[5].
• Ketamine For Suicidal Ideation's main subject is recorded as suicidal ideation^[6].
• Ketamine For Suicidal Ideation's number of participants is recorded as {'unit': '1', 'amount': '+24'}^[7].
• Ketamine For Suicidal Ideation's title is recorded as Investigating Rapid Anti-Suicidal Ideation Effects of Intravenous (IV) Ketamine in Hospitalized Patients^[8].
• Ketamine For Suicidal Ideation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[9].
• Ketamine For Suicidal Ideation's ClinicalTrials.gov ID is recorded as NCT01507181^[10].
• Ketamine For Suicidal Ideation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[11].
• Ketamine For Suicidal Ideation's research intervention is recorded as (RS)-ketamine hydrochloride^[12].
• Ketamine For Suicidal Ideation's research intervention is recorded as midazolam^[13].
• Ketamine For Suicidal Ideation's clinical trial phase is recorded as phase IV clinical trial^[14].
• Ketamine For Suicidal Ideation's research site is recorded as Icahn School of Medicine at Mount Sinai^[15].
• Ketamine For Suicidal Ideation's research subject recruitment status is recorded as completed^[16].
• Ketamine For Suicidal Ideation's study type is recorded as interventional study^[17].